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Eur J Vasc Endovasc Surg 2010;39:266-70.
Introduction: There is considerable interest in the role of novel
endovascular techniques for the treatment of patients with complex aneu-
rysms who are unsuitable for standard interventions. Knowledge of the
natural history of these lesions, as well as other co-morbidities, is required in
order that these techniques may be applied correctly in this high-risk group.
Method: This study reviews the outcome of patients deemed to be
unfit for surgery following assessment under the Scottish National Thoraco-
abdominal aneurysm service (TAAA) service (2002–2008).
Results: Of 216 patients assessed, 89 (41%) patients were considered
to be unfit for intervention. The median (interquartile range, IQR) age of
patients was 75 (70–80) years and there were 39 men (44%). Median (IQR)
aneurysm size was 6 (5.6–7.0) cm. The median (IQR) follow-up time was
12 (7–26) months. There were 49 (55%) deaths during the follow-up period
of which 23 (47%) cases were due to ruptured TAAA and 26 (53%) were not
aneurysm-related. Comparing patients with aneurysms6 cm (33 patients)
with those aneurysms 6 cm (56 patients) there was no difference in
aneurysm-related death (p  0.32) or all-cause mortality (p  0.147).
Conclusion: Aneurysm-related mortality amongst patients unsuitable
for open TAAA surgery is considerable and evolving endovascular tech-
niques may permit intervention in selected patients. However any interven-
tion can only be justified if the patient’s life expectancy is sufficient to allow
benefit to accrue.
Aorto-oesophageal and Aortobronchial Fistulae Following Thoracic
Endovascular Aortic Repair: A National Survey
Chiesa R., Melissano G., Marone E.M., Marrocco-Trischitta M.M., Kahl-
berg A. Eur J Vasc Endovasc Surg 2010;39:273-9.
Objective: We evaluated the incidence of aorto-oesophageal (AEF)
and aortobronchial (ABF) fistulae after thoracic endovascular aortic repair
(TEVAR), and investigated their clinical features, determinants, therapeutic
options and results.
Methods: We conducted a voluntary national survey among Italian
universities and hospital centres with a thoracic endovascular programme.
Results: Thirty-nine centres were contacted, and 17 participated. Of
the patients who underwent TEVAR between 1998 and 2008, 19/1113
(1.7%) developed AEF/ABF. Among indications to TEVAR, aortic pseudo-
aneurysm was associated with the development of late AEF/ABF
(P  0.009). Further, emergent and complicated procedures resulted in
increased risk of AEF/ABF (P  0.008 and P  0.001, respectively). Eight
patients were treated conservatively, all of whom died within 30 days. Eleven
patients underwent AEF/ABF surgical treatment, with a perioperative mor-
tality of 64% (7/11). At a mean follow-up of 17.7  12.5 months, overall
survival was 16% (3/19).
Conclusions: The incidence of AEF and ABF following TEVAR is not
negligible, and is comparable to that following open repair. This finding
warrants an ad hoc long-term follow-up after TEVAR, particularly in patients
submitted to emergent and complicated procedures. Both surgical and
endovascular treatment of AEF/ABF are associated with high mortality.
However, conservative treatment does not appear to be a viable option.
Diameter of the Infrarenal Aorta as a Risk Factor for Abdominal Aortic
Aneurysm: The Tromsø Study, 1994–2001
Solberg S., Forsdahl S.H., Singh K., Jacobsen B.K. Eur J Vasc Endovasc
Surg 2010;39:280-4.
Objectives: We aim to study whether the diameter of the non-aneu-
rysmatic infrarenal aorta influences the risk for abdominal aortic aneurysm
(AAA) and whether the larger diameter in men can explain the male
predominance in AAA.
Design: This is a population-based follow-up study.
Materials andmethods: In 4265men and womenwith a normal-sized
aorta in 1994-1995, 116 incident cases of AAA were diagnosed 7 years later.
The risk of an incident AAA was analysed in a multiple logistic regression
model according to baseline maximal infrarenal aortic diameter, adjusted for
known risk factors.Results: Compared with subjects with aortic diameter in the 21-23
mm bracket, men and women with a diameter 18 mm and 27 mm had
an adjusted odds ratio (OR) of 0.30 (95% confidence interval (CI): 0.10–
0.88) and 4.22 (95% CI: 1.94–9.19), respectively, for an incident AAA.
When adjusted for age and baseline aortic diameter, male sex was not
statistically significantly associated with the incidence of AAA (OR  1.45,
95% CI: 0.93–2.30, P  0.10).
Conclusions: Increased baseline diameter of the infrarenal aorta was a
highly significant, strong and independent risk factor for developing an
AAA. The larger aortic diameter in men than in women may be the most
important explanation for the higher AAA risk in men.
Endovascular Aneurysm Repair with Preservation of the Internal Iliac
Artery Using the Iliac Branch Graft Device
Karthikesalingam A., Hinchliffe R.J., Holt P.J.E., Boyle J.R., Loftus I.M.,
Thompson M.M. Eur J Vasc Endovasc Surg 2010;39:285-94.
Objectives: Aortoiliac aneurysms comprise up to 43% of the specialist
endovascular caseload. In such cases endovascular aneurysm repair (EVAR)
requires distal extension of the aortoiliac endograft beyond the ostium of the
internal iliac artery (IIA) and into the external iliac artery, conventionally
necessitating the embolisation of one or both IIA. This has been associated
with a wide range of complications, and the use of an Iliac Branch-graft
Device (IBD) offers an appealing endovascular solution.
Design: Medline, trial registries, conference proceedings and article
reference lists were searched to identify case series reporting IBD use. Data
were extracted for review.
Results: Nine series have reported the use of IBD in a total of 196
patients. Technical success was 85–100%. Median operating times were
101–290 min and median contrast dose was 58–208 g, with no aneurysm-
related mortality. Claudication developed in 12/24 patients after IBD
occlusion. One type I endoleak and two type III endoleaks occurred and
were managed endovascularly. Re-occlusion occurred in 24/196 patients.
Conclusion: IBD was performed with high technical success rates and
encouraging mid-term patency. Formalised risk stratification and morpho-
logical data are required to identify the group of patients who will benefit
most. Cost-effectiveness appraisals are needed for this technique.
Endovascular Treatment of Profunda Femoris Artery Obstructive Dis-
ease: Nonsense or Useful Tool in Selected Cases?
Donas K.P., Pitoulias G.A., Schwindt A., Schulte S., Camci M., Schlabach
R., Torsello G. Eur J Vasc Endovasc Surg 2010;39:308-13.
Background: To evaluate the therapeutic value of endovascular tech-
niques for the treatment of profunda femoris artery obstructive disease
(PFAOD) in critical limb ischaemia (CLI) patients, with technically de-
manding open profunda repair.
Design: Retrospective study of prospectively collected data of 15
consecutive CLI patients with technically demanding surgical treatment of
PFAOD, that were treated by endovascular means in two European Centers
of Vascular Surgery.
Materials: All patients had critical limb ischaemia with a history of at
least two previous vascular reconstructions in the ipsilateral groin and severe
co-morbid conditions. All patients had good common femoral artery flow,
long occlusion of the superficial femoral and popliteal arteries and impair-
ment of crural arteries.
Methods: Twelve patients underwent balloon angioplasty alone and,
in the other three cases, an additional stent placement was necessary, due to
flow-limiting dissection. The follow-up (mean 29.2  10 months) included
a surveillance protocol with the best medical treatment and duplex scanning
at 1, 3, 6, 12 months and yearly thereafter.
Results: The endovascular approach was technically successful in all
cases and the procedure-related morbidity and mortality rates were 0% for
the entire follow-up period. The 3-year primary and secondary patency rates
of the treated segment were 80% and 86.7%, respectively. The limb salvage
rate was 93.3%.
Conclusions: The outcome of our series underscores the therapeutic
value of balloon angioplasty in cases of severe PFAOD, as bailout treatment
in critical limb ischaemia patients with technically demanding open profunda
repair. This procedure can be repeated easily if significant restenosis occurs
and provides a useful tool in selected cases.
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